Page 36 - Legend Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA investigating serious risk of T-cell malignancies in CAR-T cell therapy patients

FDA investigating serious risk of T-cell malignancies in CAR-T cell therapy patients
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesSarah silbigerBristol myers squibbFood and drug administration headquartersDrug administrationGilead sciencesLegend biotech

US FDA investigating safety risk of CAR-T cancer therapies

(Reuters) -The U.S. Food and Drug Administration (FDA) said on Tuesday it was investigating cancer therapies made by companies such as Gilead Sciences, Johnson & Johnson and Novartis over the risk of hospitalizations and death due to a serious safety issue. The FDA said it had received reports of T-cell malignancies, which refer to a group of blood disorders including lymphomas and leukemias, after treatment with CAR-T therapies or chimeric antigen receptor T-cell therapies. Since 2017, six CAR T-cell therapies have been approved by the FDA and all are for the treatment of blood cancers, including lymphomas and some forms of leukemia.

New yorkUnited statesBristol myers squibb breyanziBristol myersMaju samuelPratik jainNovarti kymriahKrishna chandra eluriDrug administrationGilead sciencesBristol myers squibbLegend biotechMichael ermanFood and drug administrationOhnson johnsonBlood disorders

FDA Looking Into All Approved CAR T Therapies on Risk of Cancer in White Blood Cells

By Zaeem Shoaib The U.S. Food and Drug Administration is investigating certain CAR T cancer therapies based on reports that they might cause a type of white.

Zaeem shoaibDrug administrationArticle normalBiotechnology servicesCancer drugsHealthcare life sciencesBiological therapySpecialized drugs medicationsHealthcare provisionRegulation government policyNew products servicesProduct service approvalsCorporate industrial newsProducts servicesPolitical general newsMedical conditions

FDA probes CAR-T therapies serious risk of secondary cancer

FDA probes CAR-T therapies serious risk of secondary cancer
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Willima blairBristol myers squibb breyanziNovarti kymriahGilead science kite pharmaBristol myers squibbLegend biotechFierce pharma

FDA Looking Into All Approved CAR T Therapies on Risk of Cancer in White Blood Cells

By Zaeem Shoaib The U.S. Food and Drug Administration is investigating certain CAR T cancer therapies based on reports that they might cause a type of white blood cell to become cancerous in.

Novartis kymriahPharma tecartusBristol myers squibb abecmaZaeem shoaibDrug administrationGilead sciencesBristol myers squibbJanssen biotechLegend biotechKite pharmaDow jones